European Journal of Pharmacology 1994: Vol 263 Index

11 Pages·1994·2.3 MB·English

ELSEVIER European Journal of Pharmacology 263 (1993) 323-325
Author index
Adachi, H., see Kodama, K. (263) 93 Dianzani, C., Brunelleschi, S., Viano, 1. and Fantozzi, R.
Advenier, C., see Dumas, J.-P. (263) 17 Adenosine modulation of primed human neutrophils (263) 223
Akiyama, Y., Hara, K., Tajima, T., Murota, S.-i. and Morita, I. Dumas, J.-P., Dumas, M., Sgro, C., Advenier, C. and Giudicelli, J.-F.
Effect of vitamin K, (menatetrenone) on osteoclast-like cell Effects of two K* channel openers, aprikalim and pinacidil, on
formation in mouse bone marrow cultures (263) 181 hypoxic pulmonary vasoconstriction (263) 17
Al-Tikriti, M.S., see Laruelle, M. (263) 39 Dumas, M., see Dumas, J.-P. (263) 17
Albin, R.L., see Kume, A. (263) 163
Araki, H., see Ogawa, S.-i. (263) 9
Ebara, T., Miura, K., Okumura, M., Matsuura, T., Kim, S., Yukimura,
Artigas, F., see Ferrer, A. (263) 227 T. and Iwao, H.
Asano, M., Masuzawa-Ito, K. and Matsuda, T. Effect of adrenomedullin on renal hemodynamics and functions
Vasodilating actions of cromakalim in resting and contracting in dogs (263) 69
states of carotid arteries from spontaneously hypertensive rats Eltze, M.
(263) 121 Pathways involved in muscarinic M, and M, receptor stimulation
Aulakh, C.S., see Hulihan-Giblin, B.A. (263) 213 in rabbit vas deferens (263) 31
Baldwin, R.M., see Laruelle, M. (263) 39 Fantozzi, R., see Dianzani, C. (263) 223
Berendsen, H.H.G., Bourgondien, F.G.M. and Broekkamp, C.L.E. Fassio, A., Bonanno, G., Cavazzani, P. and Raiteri, M.
Role of dorsal and median raphe nuclei in lower lip retraction in Characterization of the GABA autoreceptor in human neocortex
rats (263) 315 as a pharmacological subtype of the GABA, receptor (263) 311
Bianchi, M., Sacerdote, P. and Panerai, A.E. Felsch, A., Stécker, K. and Borchard, U.
Fluoxetine reduces inflammatory edema in the rat: involvement Adenosine A, and A, receptor agonists alter cardiac functions
of the pituitary-adrenal axis (263) 81 and prostacyclin release in the isolated guinea-pig heart (263) 261
Bois, P., see Romey, G. (263) 101 Feng, C.J., Cheng, D.Y., Kaye, A.D., Kadowitz, PJ. and Nossaman,
Bonanno, G., see Fassio, A. (263) 311 B.D.
Borchard, U., see Felsch, A. (263) 261 Influence of N“-nitro-.-arginine methyl ester, LY83583, glyben-
Bourgondien, F.G.M., see Berendsen, H.H.G. (263) 315 clamide and L158809 on pulmonary circulation (263) 133
Breslow, M.J., see Clarkson, K. (263) R1 Ferrer, A. and Artigas, F.
Brodin, E., see Brodin, K. (263) 175 Effects of single and chronic treatment with tranylcypromine on
Brodin, K.., Ogren, S.-O. and Brodin, E. extracellular serotonin in rat brain (263) 227
Clomipramine and clonazepam increase cholecystokinin levels in Ferrone, R.A., see Lysko, G.S. (263) 25
rat ventral tegmental area and limbic regions (263) 175 Fibiger, H.C., see Day, J.C. (263) 285
Broekkamp, C.L.E., see Berendsen, H.H.G. (263) 315 Funada, M., see Suzuki, T. (263) 207
Brunelleschi, S., see Dianzani, C. (263) 223
Giudicelli, J.-F., see Dumas, J.-P. (263) 17
Carlsson, A., see Svensson, K. (263) 235 Gupta, M.B., see Nath, C. (263) 203
Carter, M.F., see Von Lubitz, D.K.J.E. (263) 59
Casto, R., see Lysko, G.S. (263) 25 Hanson, P.J., see Price, K.J. (263) 199
Cavazzani, P., see Fassio, A. (263) 311 Hara, K., see Akiyama, Y. (263) 181
Cervo, L., Rossi, C., Tatarczynska, E. and Samanin, R. Heller, B., see Izenwasser, S. (263) 277
Role of 5-HT,, receptors in the antinociceptive action of 8-hy- Hoffer, P.B., see Laruelle, M. (263) 39
droxy-2-(di-n-propylamino)tetralin in the rat (263) 187 Honkanen, A., see Wegelius, K. (263) 141
Chapman, M.A., see See, R.E. (263) 269 Hu, X.-H., Tang, H.-W., Li, Q.-S. and Huang, X.-F.
Charney, D.S., see Laruelle, M. (263) 39 Central mechanism of indomethacin analgesia (263) 53
Cheng, D.Y., see Feng, C.J. (263) 133 Huang, X.-F., see Hu, X.-H. (263) 53
Clarkson, K., Tobin, J.R. and Breslow, M.J. Huff, R.M., see Svensson, K. (263) 235
Atypical B-adrenoceptor in bovine adrenal medulla (263) R1 Hulihan-Giblin, B.A., Park, Y.D. and Aulakh, C.S.
Cohen, G., see Werner, P. (263) 157 Differential effects of chronic antidepressant treatment on S-HT)-
Connor, H.E., see O’Shaughnessy, C.T. (263) 193 receptor binding sites in Wistar rat brain (263) 213
Humphrey, P.P.A., see Khakh, B.S. (263) 301
Day, J.C., Tham, C.-S. and Fibiger, H.C.
Dopamine depletion attenuates amphetamine-induced increases Inaguma, K., see Ito, M. (263) 253
of cortical acetylcholine release (263) 285 Ingram, D.K., see Shimada, A. (263) 293
Dhawan, K.N., see Nath, C. (263) 203 Innis, R.B., see Laruelle, M. (263) 39
324 Author index / European Journal of Pharmacology 263 (1994) 323-325
Ito, M., Segami, T., Inaguma, K. and Suzuki, Y. Nikolsky, E.E., see Shakiryanova, D.M. (263) 107
Cimetidine and omeprazole accelerate gastric ulcer healing by an Nossaman, B.D., see Feng, C.J. (263) 133
increase in gastrin secretion (263) 253
Ito, M., Segami, T., Tsukahara, T., Kojima, R. and Suzuki, Y. Ogawa, S.-i., Okuyama, S., Araki, H. and Otomo, S.
Effect of cimetidine and omeprazole on gastric ulcer healing of Effect of NE-100, a novel o receptor ligand, on phencyclidine-in-
rats with limited food intake time (263) 245 _ duced cognitive dysfunction (263) 9
Iwao, H., see Ebara, T. (263) 69 Ogren, S.-O., see Brodin, K. (263) 175
Izenwasser, S., Terry, P., Heller, B., Witkin, J.M. and Katz, J.L. Okamura, T. and Toda, N.
Differential relationships among dopamine transporter affinities Mechanism underlying nicotine-induced relaxation in dog saphe-
and stimulant potencies of various uptake inhibitors (263) 277 nous arteries (263) 85
Okumura, M., see Ebara, T. (263) 69
Jacobson, K.A., see Von Lubitz, D.K.J.E. (263) 59 Okuyama, S., see Ogawa, S.-i. (263) 9
O’Shaughnessy, C.T. and Connor, H.E.
Kadowitz, P.J., see Feng, C.J. (263) 133 Investigation of the role of tachykinin NK,, NK, receptors and
Katz, J.L., see Izenwasser, S. (263) 277 CGRP receptors in neurogenic plasma protein extravasation in
Kaye, A.D., see Feng, C.J. (263) 133 dura mater (263) 193
Khakh, B.S., Michel, A. and Humphrey, P.P.A. Otomo, S., see Ogawa, S.-i. (263) 9
Estimates of antagonist affinities at P,, purinoceptors in rat vas
deferens (263) 301 Panerai, A.E., see Bianchi, M. (263) 81
Kim, S., see Ebara, T. (263) 69 Papp, M. and Moryl, E.
Kim, Y.-H., see Suh, H.-W. (263) 217 Antidepressant activity of non-competitive and competitive
Kling-Petersen, T., see Svensson, K. (263) 235 NMDA receptor antagonists in a chronic mild stress model of
Kodama, K., Adachi, H., Mori, N. and Saito, I. depression (263) 1
Effects of a novel, selective and potent phosphodiesterase type V Park, Y.D., see Hulihan-Giblin, B.A. (263) 213
inhibitor, E4021, on myocardial ischemia in guinea pigs (263) 93 Patnaik, G.K., see Nath, C. (263) 203
Kojima, R., see Ito, M. (263) 245 Pechnick, R.N. and Poland, R.E.
Korpi, E.R., see Wegelius, K. (263) 141 Neuroendocrine responses produced by enantiomeric pairs of
Kume, A. and Albin, R.L. drugs that interact with phencyclidine and o receptors (263) 115
Quantitative autoradiography of 4’-ethynyl-4-n-(2,,3-} p*rHo - Poland, R.E., see Pechnick, R.N. (263) 115
pylbicycloorthobenzoate binding to the GABA, receptor com- Popik, P., see Von Lubitz, D.K.J.E. (263) 59
plex (263) 163 Price, K.J., Hanson, P.J. and Whittle, B.J.R.
Kung, H.F., see Laruelle, M. (263) 39 Stimulation by carbachol of mucus gel thickness in rat stomach
involves nitric oxide (263) 199
Laruelle, M., Al-Tikriti, M.S., Zea-Ponce, Y., Zoghbi, S.S., Baldwin,
R.M., Charney, D.S., Hoffer, P.B., Kung, H.F. and Innis, R.B. Raiteri, M., see Fassio, A. (263) 311
In vivo quantification of dopamine D, receptor parameters in Robinson, J.L., see Lysko, G.S. (263) 25
nonhuman primates with ['7*Ijiodobenzofuran and single photon Romey, G., Bois, P. and Lazdunski, M.
emission computerized tomography (263) 39 Effects of two chemically related new Ca?* channel antagonists,
Lazdunski, M., see Romey, G. (263) 101 $R33557 (fantofarone) and $R33805, on the L-type cardiac chan-
Li, Q.-S., see Hu, X.-H. (263) 53 nel (263) 101
Lin, R.C.-S., see Von Lubitz, D.K.J.E. (263) 59 Ronken, E., Mulder, A.H. and Schoffelmeer, A.N.M.
London, E.D., see Shimada, A. (263) 293 Glucocorticoid and mineralocorticoid receptors differentially
Lysko, G.S., Robinson, J.L., Casto, R. and Ferrone, R.A. modulate cultured dopaminergic neurons of rat ventral mesen-
The stereospecific effects of isoflurane isomers in vivo (263) 25 cephalon (263) 149
Rossi, C., see Cervo, L. (263) 187
Masuzawa-Ito, K., see Asano, M. (263) 121
Matsuda, T., see Asano, M. (263) 121 Sacerdote, P., see Bianchi, M. (263) 81
Matsuura, T., see Ebara, T. (263) 69 Saito, 1., see Kodama, K. (263) 93
Michel, A., see Khakh, B.S. (263) 301 Samanin, R., see Cervo, L. (263) 187
Misawa, M., see Suzuki, T. (263) 207 Schoffelmeer, A.N.M., see Ronken, E. (263) 149
Miura, K., see Ebara, T. (263) 69 See, R.E. and Chapman, M.A.
Miyauchi, Y. and Uchida, M.K. Chronic haloperidol, but not clozapine, produces altered oral
Ca?*-inhibition of Ca?*-induced small contraction of rat uterine movements and increased extracellular glutamate in rats (263)
smooth muscle (263) 75 269
Mori, N., see Kodama, K. (263) 93 Segami, T., see Ito, M. (263) 245
Mori, T., see Suzuki, T. (263) 207 Segami, T., see Ito, M. (263) 253
Morita, I., see Akiyama, Y. (263) 181 Sgro, C., see Dumas, J.-P. (263) 17
Moryl, E., see Papp, M. (263) 1 Shakiryanova, D.M., Zefirov, A.L., Nikolsky, E.E. and Vyskoéil, F.
Mulder, A.H., see Ronken, E. (263) 149 The effect of acetylcholine and related drugs on currents at the
Murota, S.-i., see Akiyama, Y. (263) 181 frog motor nerve terminal (263) 107
Mytilineou, C., see Werner, P. (263) 157 Shimada, A., Spangler, E.L., London, E.D. and Ingram, D.K.
Spermidine potentiates dizocilpine-induced impairment of learn-
Nagase, H., see Suzuki, T. (263) 207 ing performance by rats in a 14-unit T-maze (263) 293
Nath, C., Gupta, M.B., Patnaik, G.K. and Dhawan, K.N. Song, D.-K., see Suh, H.-W. (263) 217
Morphine-induced straub tail response: mediated by central y»- Spangler, E.L., see Shimada, A. (263) 293
opioid receptor (263) 203 Stécker, K., see Felsch, A. (263) 261
Author index / European Journal of Pharmacology 263 (1994) 323-325
Suh, H.-W., Song, D.-K., Kim, Y.-H., Yoo, J.-S. and Tseng, L.F. Viano, I., see Dianzani, C. (263) 223
Differential antagonism by MK-801 against antinociception in- Von Lubitz, D.K.J.E., Lin, R.C.-S., Popik, P., Carter, M.F. and
duced by opioid receptor agonists administered supraspinally in Jacobson, K.A.
mice (263) 217 Adenosine A, receptor stimulation and cerebral ischemia (263)
Suzuki, T., Mori, T., Funada, M., Misawa, M. and Nagase, H. 59
Attenuation of the discriminative stimulus properties of cocaine Vyskoéil, F., see Shakiryanova, D.M. (263) 107
by 5-opioid receptor antagonists (263) 207
Suzuki, Y., see Ito, M. (263) 245 Waters, N., see Svensson, K. (263) 235
Suzuki, Y., see Ito, M. (263) 253 Wegelius, K., Honkanen, A. and Korpi, E.R.
Svensson, K., Carlsson, A., Huff, R.M., Kling-Petersen, T. and Benzodiazepine receptor ligands modulate ethanol drinking in
Waters, N. alcohol-preferring rats (263) 141
Behavioral and neurochemical data suggest functional differences Wei, E.T. and Thomas, H.A.
between dopamine D, and D, receptors (263) 235 Correlation of neuroendocrine and anti-edema activities of ala-
nine-corticotropin-releasing factor analogs (263) 319
Tajima, T., see Akiyama, Y. (263) 181 Werner, P., Mytilineou, C., Cohen, G. and Yahr, M.D.
Tang, H.-W., see Hu, X.-H. (263) 53 Impaired oxidation of pyruvate in human embryonic fibroblasts
Tatarczynska, E., see Cervo, L. (263) 187 after exposure to L-dopa (263) 157
Terry, P., see Izenwasser, S. (263) 277 Whittle, B.J.R., see Price, KJ. (263) 199
Tham, C.-S., see Day, J.C. (263) 285 Witkin, J.M., see Izenwasser, S. (263) 277
Thomas, H.A., see Wei, E.T. (263) 319
Yahr, M.D., see Werner, P. (263) 157
Tobin, J.R., see Clarkson, K. (263) R1
Yoo, J.-S., see Suh, H.-W. (263) 217
Toda, N., see Okamura, T. (263) 85
Yukimura, T., see Ebara, T. (263) 69
Tseng, L.F., see Suh, H.-W. (263) 217
Tsukahara, T., see Ito, M. (263) 245 Zea-Ponce, Y., see Laruelle, M. (263) 39
Zefirov, A.L., see Shakiryanova, D.M. (263) 107
Uchida, M.K., see Miyauchi, Y. (263) 75 Zoghbi, S.S., see Laruelle, M. (263) 39

European Journal of Pharmacology 263 (1994) 327-333
Key word index
Acetylcholine LY83583; L158809; Glybenclamide; Guanylate cyclase, soluble; K*
Nerve terminal current; Cholinomimetic; Anticholinesterase channel, ATP-sensitive; Hypoxia; Pulmonary circulation; Hypoxic
(Shakiryanova, D.M. (263) 107) pulmonary vasoconstriction; Pulmonary vascular bed, rat (Feng, C.J.
(263) 133)
d-Amphetamine; Cortex; Dopamine; 6-Hydroxydopamine; Nora-
drenaline (Day, J.C. (263) 285) Anhedonia
Depression, animal model; MK-801; CGP 37849; CGP 40116;
Acid secretion Imipramine; (Rat) (Papp, M. (263) 1)
Cimetidine; Omeprazole; Gastrin (Ito, M. (263) 253)
Anticholinesterase
ACTH (adrenocorticotropic hormone)
Nerve terminal current; Cholinomimetic; Acetylcholine (Shaki-
Corticosterone; Dioxadrol; Endocrine; NMDA (N-methyl-p-aspar-
ryanova, D.M. (263) 107)
tate); Pentazocine; Phencyclidine; o Receptor; SKF 10,047 (Pech-
nick, R.N. (263) 115)
Antidepressant
5-HT (5-hydroxytryptamine, serotonin) release; Monoamine oxidase
ACTH (adrenocorticotropin) release
inhibitor; Microdialysis, intracerebral (Ferrer, A. (263) 227)
CRF (corticotropin-releasing factor); Anti-edema; (Structure-activity
relationship) (Wei, E.T. (263) 319)
Antidepressant drug
Actin filament Hypothalamic-pituitary-adrenal axis; Inflammation; 5-HT (5-hy-
Ca?* inhibition; Contraction; Smooth muscle; Myometrium; Thresh- droxytryptamine, serotonin) (Bianchi, M. (263) 81)
old phenomenon (Miyauchi, Y. (263) 75)
Anti-edema
Adenosine receptor CRF (corticotropin-releasing factor); ACTH (adrenocorticotropin)
Brain ischemia, therapy; Cerebral blood flow; (Gerbil) (Von Lubitz, release; (Structure-activity relationship) (Wei, E.T. (263) 319)
D.K.J.E. (263) 59)
An tinociception
Priming; Neutrophil, human (Dianzani, C. (263) 223) 5-HT,, receptor; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetra-
lin); Pain transmission; (Rat) (Cervo, L. (263) 187)
Adenosine receptor antagonist; Heart, guinea-pig, perfused; Prosta-
cyclin (Felsch, A. (263) 261) Arterial smooth muscle relaxation
Cromakalim; K* channel, ATP-sensitive; K* channel, Ca’*-
Adenosine receptor antagonist activated; Spontaneously hypertensive rat (SHR) (Asano, M. (263)
Adenosine receptor; Heart, guinea-pig, perfused; Prostacyclin 121)
(Felsch, A. (263) 261)
B,-Adrenoceptor
EBOB (4’-ethynyl-4-n-propylbicycloorthobenzoate), GABA, recep-
Catecholamine; Radioligand binding (Clarkson, K. (263) R1) tor complex; Picrotoxin; Brain, human (Kume, A. (263) 163)
Adrenomedullin
Benzamide
Renal hemodynamics; Renal function (Ebara, T. (263) 69)
Dopamine; Dopamine D, receptor; SPECT (single photon emission
computed tomography); ['2>1}lodobenzofuran (Laruelle, M. (263) 39)
d-Amphetamine
Acetylcholine; Cortex; Dopamine; 6-Hydroxydopamine; Nora-
drenaline (Day, J.C. (263) 285)
Ethanol drinking; GABA, receptor; Naloxone; (Selected rat lines)
Analgesia (Wegelius, K. (263) 141)
Indomethacin; Norepinephrine; B-Endorphin; Phentolamine; Nalox-
one; Pain (Hu, X.-H. (263) 53) 7. B nmzZy ALA, hee
Cocaine; Drug discrimination; Naltrindole; Naltriben (Suzuki, T.
Anesthetic (263) 207)
Receptor; Stereoisomer; Isoflurane; (Rat) (Lysko, G.S. (263) 25)
Bone marrow culture
Angiotensin AT, receptor antagonist Vitamin K,; Osteoclast-like cell formation; 1,25-Dihydroxyvitamin
Nitric oxide (NO) synthesis; N“-Nitro-.-arginine methyl ester; D, (Akiyama, Y. (263) 181)
328 Key word index / European Journal of Pharmacology 263 (1994) 327-333
Brain, human
EBOB (4’-ethynyl-4-n-propylbicycloorthobenzoate); GABA, recep- 5-HT,- receptor; [*H]Mesulergine; Imipramine; Clorgyline; (Wistar
tor complex; Picrotoxin; Autoradiography (Kume, A. (263) 163) rat) (Hulihan-Giblin, B.A. (263) 213)
Brain ischemia, therapy Clonazepam
Adenosine receptor; Cerebral blood flow; (Gerbil) (Von Lubitz, CCK (cholecystokinin); Substance P; Monoamine uptake inhibitor;
D.K.J.E. (263) 59) Panic disorder; Central nervous system, rat (Brodin, K. (263) 175)
L-type Ca?* channel Clorgyline
Heart; Voltage clamp; Ca?* channel antagonist; $R33557; SR33805 5-HT,. receptor; [*HJMesulergine; Clomipramine; Imipramine;
(Romey, G. (263) 101) (Wistar rat) (Hulihan-Giblin, B.A. (263) 213)
Ca** channel antagonist Clozapine
Heart; L-type Ca?* channel; Voltage clamp; $R33557; SR33805 Haloperidol; Microdialysis; Striatum; Glutamate; GABA (y-
(Romey, G. (263) 101) aminobutyric acid) (See, R.E. (263) 269)
Ca** inhibition Cocaine
Contraction; Smooth muscle; Myometrium; Threshold phenomenon; Drug discrimination; Naltrindole; Naltriben; 7-Benzylidenenaltre-
xone (Suzuki, T. (263) 207)
Actin filament (Miyauchi, Y. (263) 75)
Catecholamine Dopamine uptake; Dopamine transporter (Izenwasser, S. (263) 277)
B,-Adrenoceptor; Radioligand binding (Clarkson, K. (263) R1)
Cognition
NE-100; o Receptor; Phencyclidine; Neuroleptic; (Rat) (Ogawa, S.-i.
CCK (cholecystokinin)
(263) 9)
Substance P; Clonazepam; Monoamine uptake inhibitor; Panic disor-
der; Central nervous system, rat (Brodin, K. (263) 175)
Contraction
Ca?* inhibition; Smooth muscle; Myometrium; Threshold phe-
Central nervous system, rat
nomenon; Actin filament (Miyauchi, Y. (263) 75)
CCK (cholecystokinin); Substance P; Clonazepam; Monoamine up-
take inhibitor; Panic disorder (Brodin, K. (263) 175)
Coronary vasodilator
E4021; Phosphodiesterase type V inhibitor; CGMP; Vasopressin; ST
Cerebral blood flow
segment elevation (Kodama, K. (263) 93)
Adenosine receptor; Brain ischemia, therapy; (Gerbil) (Von Lubitz,
D.K.J.E. (263) 59)
Cortex
Acetylcholine; d-Amphetamine; Dopamine; 6-Hydroxydopamine;
CGP 35348
Noradrenaline (Day, J.C. (263) 285)
Neocortex, human; GABA (y-aminobutyric acid) release; GABA,
autoreceptor; CGP 52432; Phaclofen (Fassio, A. (263) 311)
Corticosteroid
Primary neuronal culture; Ventral mesencephalon; x-Opioid recep-
CGP 37849
tor; [*H]Dopamine release; Sensitization (Ronken, E. (263) 149)
Depression, animal model; Anhedonia; MK-801; CGP 40116;
Imipramine; (Rat) (Papp, M. (263) 1) Corticosterone
ACTH (adrenocorticotropic hormone); Dioxadrol; Endocrine;
CGP 40116 NMDA (N-methyl-p-aspartate); Pentazocine; Phencyclidine; 7 Re-
Depression, animal model; Anhedonia; MK-801; CGP 37849; ceptor; SKF 10,047 (Pechnick, R.N. (263) 115)
Imipramine; (Rat) (Papp, M. (263) 1)
CRF (corticotropin-releasing factor)
CGP 52432 Anti-edema; ACTH (adrenocorticotropin) release; (Structure-activity
Neocortex, human; GABA (y-aminobutyric acid) release; GABA, relationship) (Wei, E.T. (263) 319)
autoreceptor; CGP 35348; Phaclofen (Fassio, A. (263) 311)
Cromakalim
CGRP (calcitonin gene-related peptide) Arterial smooth muscle relaxation; K* channel, ATP-sensitive; K*
Saphenous artery; Vasodilator nerve; Nitric oxide (NO); Nicotine channel, Ca?*-activated; Spontaneously hypertensive rat (SHR)
(Okamura, T. (263) 85) (Asano, M. (263) 121)
Cholinomimetic Depression, animal model
Nerve terminal current; Acetylcholine; Anticholinesterase (Shakir- Anhedonia; MK-801; CGP 37849; CGP 40116; Imipramine; (Rat)
yanova, D.M. (263) 107) (Papp, M. (263) 1)
Cibacron blue 1,9-Dideoxy-forskolin
P;, purinoceptor; iso-PPADS (pyridoxalphosphate-6-azophenyl- Muscarinic M, receptor; Muscarinic M, receptor; Mechanistic path-
2',S'-disulphonic acid); Suramin (Khakh, B.S. (263) 301) way; LiCl; Forskolin; Phorbol ester; Vas deferens; (Rabbit) (Eltze,
M. (263) 31)
Cimetidine
Gastric ulcer; Omeprazole; Gastrin; Gastric acid (Ito, M. (263) 245) 1,25-Dihydroxyvitamin D,
Vitamin K,; Bone marrow culture; Osteoclast-like cell formation
Omeprazole; Acid secretion; Gastrin (Ito, M. (263) 253) (Akiyama, Y. (263) 181)
Key word index / European Journal of Pharmacology 263 (1994) 327-333
Dioxadrol B-Endorphin
ACTH (adrenocorticotropic hormone); Corticosterone; Endocrine; Indomethacin; Analgesia; Norepinephrine; Phentolamine; Naloxone;
NMDA (N-methyl-p-aspartate); Pentazocine; Phencyclidine; 0 Re- Pain (Hu, X.-H. (263) 53)
ceptor; SKF 10,047 (Pechnick, R.N. (263) 115)
Morphine; MK-801; Tail-flick inhibition; Hot plate inhibition (Suh,
L-DOPA (3,4-dihyd henylalanine) H.-W. (263) 217)
Mitochondrion; Fibroblast; Parkinson’s disease; Pyruvate oxidation
(Werner, P. (263) 157) Ethanol drinking
GABA, receptor; Benzodiazepine; Naloxone; (Selected rat lines)
Dopamine (Wegelius, K. (263) 141)
Dopamine D, receptor; SPECT (single photon emission computed
tomography); Benzamide; ['*Ilodobenzofuran (Laruelle, M. (263) Fibroblast
39) L-DOPA (3,4-dihydroxyphenylalanine); Mitochondrion; Parkinson’s
disease; Pyruvate oxidation (Werner, P. (263) 157)
Acetylcholine; d-Amphetamine; Cortex; 6-Hydroxydopamine; Nora-
drenaline (Day, J.C. (263) 285) Forskolin
Muscarinic M, receptor; Muscarinic M, receptor; Mechanistic path-
Dopamine D, receptor way; LiCl; 1,9-Dideoxy-forskolin; Phorbol ester; Vas deferens; (Rab-
Dopamine; SPECT (single photon emission computed tomography); bit) (Eltze, M. (263) 31)
Benzamide; {'**I}lodobenzofuran (Laruelle, M. (263) 39)
GABA, autoreceptor
Dopamine D, receptor Neocortex, human; GABA (y-aminobutyric acid) release; CGP 35348;
Locomotor activity; Dopamine release; Mitogenesis (Svensson, K. CGP 52432; Phaclofen (Fassio, A. (263) 311)
(263) 235)
GABA (y-aminobutyric acid)
Dopamine release Haloperidol; Clozapine; Microdialysis; Striatum; Glutamate (See,
Dopamine D, receptor; Locomotor activity; Mitogenesis (Svensson, R.E. (263) 269)
K. (263) 235)
GABA (y-aminobutyric acid) release
[7H] Dopamine release Neocortex, human; GABA, autoreceptor; CGP 35348; CGP 52432;
Primary neuronal culture; Ventral mesencephalon; «-Opioid recep- Phaclofen (Fassio, A. (263) 311)
tor; Sensitization; Corticosteroid (Ronken, E. (263) 149)
GABA, receptor
Dopamine transporter Ethanol drinking; Benzodiazepine; Naloxone; (Selected rat lines)
Dopamine uptake; Cocaine (Izenwasser, S. (263) 277) (Wegelius, K. (263) 141)
Dopamine uptake GABA, receptor complex
Cocaine; Dopamine transporter (Izenwasser, S. (263) 277) EBOB (4’-ethynyl-4-n-propylbicycloorthobenzoate), Picrotoxin;
Brain, human; Autoradiography (Kume, A. (263) 163)
Dorsal raphe nucleus
Lower lip retraction; Median raphe nucleus; 5-HT,, receptor ago- Gastric acid
nist; 8-OH-DPAT ((+ )-8-hydroxy-(di-n-propylamino)tetralin), (Rat) Gastric ulcer; Cimetidine; Omeprazole; Gastrin (Ito, M. (263) 245)
(Berendsen, H.H.G. (263) 315)
Gastric mucosa
Drug discrimination Nitric oxide (NO); Mucus; Stomach (Price, K.J. (263) 199)
Cocaine; Naltrindole; Naltriben; 7-Benzylidenenaltrexone (Suzuki,
T. (263) 207) Gastric ulcer
Cimetidine; Omeprazole; Gastrin; Gastric acid (Ito, M. (263) 245)
Dura mater
Plasma protein extravasation; Tachykinin NK, receptor, a~CGRP- Gastrin
(8-37), GR82334 (O’Shaughnessy, C.T. (263) 193) Gastric ulcer; Cimetidine; Omeprazole; Gastric acid (Ito, M (263)
245)
E4021
Phosphodiesterase type V inhibitor; cGMP; Coronary vasodilator; Cimetidine; Omeprazole; Acid secretion (Ito, M. (263) 253)
Vasopressin; ST segment elevation (Kodama, K. (263) 93)
Glutamate
EBOB (4’-ethynyl-4-n-propyibicycloorthobenzoate ) Haloperidol; Clozapine; Microdialysis; Striatum; GABA (y-
GABA , receptor complex; Picrotoxin; Brain, human; Autoradiogra- aminobutyric acid) (See, R.E. (263) 269)
phy (Kume, A. (263) 163)
Glutamate receptor
EDRF (endothelium-derived relaxing factor) Polyamine; Memory; lon channel (Shimada, A. (263) 293)
K* channel opener; K* channel blocker; Hypoxia; Lung; Smooth
muscle, vascular (Dumas, J.-P. (263) 17)
Nitric oxide (NO) synthesis; N”-Nitro-.-arginine methyl ester;
Endocrine LY83583; L158809; Guanylate cyclase, soluble; K* channel, ATP-
ACTH (adrenocorticotropic hormone); Corticosterone; Dioxadrol; sensitive; Angiotensin AT, receptor antagonist; Hypoxia; Pulmonary
NMDA (N-methyl-p-aspartate); Pentazocine; Phencyclidine; 7 Re- circulation; Hypoxic pulmonary vasoconstriction; Pulmonary vascular
ceptor; SKF 10,047 (Pechnick, R.N. (263) 115) bed, rat (Feng, C.J. (263) 133)
330 Key word index / European Journal of Pharmacology 263 (1994) 327-333
cGMP Nitric oxide (NO) synthesis; N“®-Nitro-.-arginine methyl ester;
E4021; Phosphodiesterase type V inhibitor; Coronary vasodilator; LY83583; L158809; Glybenclamide; Guanylate cyclase, soluble; K*
Vasopressin; ST segment elevation (Kodama, K. (263) 93) channel, ATP-sensitive; Angiotensin AT, receptor antagonist; Pul-
monary circulation; Hypoxic pulmonary vasoconstriction; Pulmonary
GR82334 vascular bed, rat (Feng, C.J. (263) 133)
Plasma protein extravasation; Dura mater; Tachykinin NK, receptor,
a-CGRP-~8-—37) (O’Shaughnessy, C.T. (263) 193) pulmonary vasoconstriction
Nitric oxide (NO) synthesis; N“-Nitro-.-arginine methyl ester;
LY83583; L158809; Glybenclamide; Guanylate cyclase, soluble; K*
Guanylate cyclase, soluble
channel, ATP-sensitive; Angiotensin AT, receptor antagonist; Hy-
Nitric oxide (NO) synthesis; N“®-Nitro-.-arginine methyl ester;
poxia; Pulmonary circulation; Pulmonary vascular bed, rat (Feng,
LY83583; L158809; Glybenclamide; K* channel, ATP-sensitive; An-
C.J. (263) 133)
giotensin AT, receptor antagonist; Hypoxia; Pulmonary circulation;
Hypoxic pulmonary vasoconstriction; Pulmonary vascular bed, rat
Imipramine
(Feng, C.J. (263) 133)
Depression, animal model; Anhedonia; MK-801; CGP 37849; CGP
40116; (Rat) (Papp, M. (263) 1)
Haloperidol
Clozapine; Microdialysis; Striatum; Glutamate; GABA (y-aminobu- 5-HT,< receptor; [*HJMesulergine; Clomipramine; Clorgyline;
tyric acid) (See, R.E. (263) 269) (Wistar rat) (Hulihan-Giblin, B.A. (263) 213)
Heart Indomethacin
L-type Ca?* channel; Voltage clamp; Ca?* channel antagonist; Analgesia; Norepinephrine; B-Endorphin; Phentolamine; Naloxone;
$R33557; SR33805 (Romey, G. (263) 101) Pain (Hu, X.-H. (263) 53)
Inflammation
Heart, guinea-pig, perfused
Antidepressant drug; Hypothalamic-pituitary-adrenal axis; 5-HT (5-
Adenosine receptor; Adenosine receptor antagonist; Prostacyclin
(Felsch, A. (263) 261) hydroxytryptamine, serotonin) (Bianchi, M. (263) 81)
('*1]lodobenzofuran
Hot plate inhibition Dopamine; Dopamine D, receptor; SPECT (single photon emission
B-Endorphin; Morphine; MK-801; Tail-flick inhibition (Suh, H.-W. computed tomography); Benzamide (Laruelle, M. (263) 39)
(263) 217)
lon channel
5-HT (5-hydroxytryptamine, serotonin) Glutamate receptor; Polyamine; Memory (Shimada, A. (263) 293)
Antidepressant drug; Hypothalamic-pituitary-adrenal axis; Inflam-
mation (Bianchi, M. (263) 81) Isoflurane
Anesthetic; Receptor; Stereoisomer; (Rat) (Lysko, G.S. (263) 25)
5-HT (5-hydroxytryptamine, serotonin) release
Monoamine oxidase inhibitor; Antidepressant; Microdialysis, intrac- K* channel, ATP-sensitive
erebral (Ferrer, A. (263) 227) Cromakalim; Arterial smooth muscle relaxation; K* channel, Ca?*-
activated; Spontaneously hypertensive rat (SHR) (Asano, M. (263)
121)
5-HT,, receptor
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); Pain trans-
Nitric oxide (NO) synthesis; N®-Nitro-L-arginine methyl ester;
mission; Antinociception; (Rat) (Cervo, L. (263) 187)
LY83583; L158809; Glybenclamide; Guanylate cyclase, soluble; An-
giotensin AT, receptor antagonist; Hypoxia; Pulmonary circulation;
5-HT,< receptor Hypoxic pulmonary vasoconstriction; Pulmonary vascular bed, rat
(?H]Mesulergine; Clomipramine; Imipramine; Clorgyline; (Wistar (Feng, C.J. (263) 133)
rat) (Hulihan-Giblin, B.A. (263) 213)
K * channel blocker
5-HT,, receptor agonist EDRF (endothelium-derived relaxing factor); K* channel opener;
Lower lip retraction; Dorsal raphe nucleus; Median raphe nucleus; Hypoxia; Lung; Smooth muscle, vascular (Dumas, J.-P. (263) 17)
8-OH-DPAT ((+)-8-hydroxy-(di-n-propylamino)tetralin); (Rat)
(Berendsen, H.H.G. (263) 315) K* channel, Ca?*-activated
Cromakalim; Arterial smooth muscle relaxation; K* channel, ATP-
6-Hydroxydopamine sensitive; Spontaneously hypertensive rat (SHR) (Asano, M. (263)
121)
Acetylcholine; d-Amphetamine; Cortex; Dopamine; Noradrenaline
(Day, J.C. (263) 285)
K* channel opener
EDRF (endothelium-derived relaxing factor); K* channel blocker;
Hypothalamic-pituitary-adrenal axis
Hypoxia; Lung; Smooth muscle, vascular (Dumas, J.-P. (263) 17)
Antidepressant drug; Inflammation; 5-HT (5-hydroxytryptamine,
serotonin) (Bianchi, M. (263) 81) L158809
Nitric oxide (NO) synthesis; N“-Nitro-.-arginine methyl ester;
Hypoxia LY83583; Glybenclamide; Guanylate cyclase, soluble; K* channel,
EDRF (endothelium-derived relaxing factor); K* channel opener; ATP-sensitive; Angiotensin AT, receptor antagonist; Hypoxia; Pul-
K* channel blocker; Lung; Smooth muscle, vascular (Dumas, J.-P. monary circulation; Hypoxic pulmonary vasoconstriction; Pulmonary
(263) 17) vascular bed, rat (Feng, C.J. (263) 133)
Key word index / European Journal of Pharmacology 263 (1994) 327-333
Lic! Monoamine oxidase inhibitor
Muscarinic M, receptor; Muscarinic M, receptor; Mechanistic path- 5-HT (S5-hydroxytryptamine, serotonin) release; Antidepressant; Mi-
way; Forskolin; 1,9-Dideoxy-forskolin; Phorbol ester; Vas deferens; crodialysis, intracerebral (Ferrer, A. (263) 227)
(Rabbit) (Eltze, M. (263) 31)
Monoamine uptake inhibitor
Locomotor activity CCK (cholecystokinin); Substance P; Clonazepam; Panic disorder;
Dopamine D, receptor; Dopamine release; Mitogenesis (Svensson, Central nervous system, rat (Brodin, K. (263) 175)
K. (263) 235)
Morphine
Lower lip retraction Straub tail; 4 ,-Opioid receptor (Nath, C. (263) 203)
Dorsal raphe nucleus; Median raphe nucleus; 5-HT,, receptor ago-
B-Endorphin; MK-801; Tail-flick inhibition; Hot plate inhibition
nist; 8-OH-DPAT ((+ )-8-hydroxy-(di-n-propylamino)tetralin); (Rat)
(Suh, H.-W. (263) 217)
(Berendsen, H.H.G. (263) 315)
Mucus
Nitric oxide (NO); Gastric mucosa; Stomach (Price, K.J. (263) 199)
EDRF (endothelium-derived relaxing factor); K* channel opener;
K* channel blocker; Hypoxia; Smooth muscle, vascular (Dumas, Muscarinic M, receptor
J.-P. (263) 17) Muscarinic M, receptor; Mechanistic pathway; LiCl; Forskolin; 1,9-
Dideoxy-forskolin; Phorbol ester; Vas deferens; (Rabbit) (Eltze, M.
LY83583 (263) 31)
Nitric oxide (NO) synthesis; N“®-Nitro-L-arginine methyl ester;
L158809; Glybenclamide; Guanylate cyclase, soluble; K* channel, Muscarinic M, receptor
ATP-sensitive; Angiotensin AT, receptor antagonist; Hypoxia; Pul- Muscarinic M, receptor; Mechanistic pathway; LiCl; Forskolin; 1,9-
monary circulation; Hypoxic pulmonary vasoconstriction; Pulmonary Dideoxy-forskolin; Phorbol ester; Vas deferens; (Rabbit) (Eltze, M.
vascular bed, rat (Feng, C.J. (263) 133) (263) 31)
Mechanistic pathway Myometrium
Muscarinic M, receptor; Muscarinic M, receptor; LiCl; Forskolin; Ca** inhibition; Contraction; Smooth muscle; Threshold phe-
1,9-Dideoxy-forskolin; Phorbol ester; Vas deferens; (Rabbit) (Eltze, nomenon; Actin filament (Miyauchi, Y. (263) 75)
M. (263) 31)
Naloxone
Median raphe nucleus Indomethacin; Analgesia; Norepinephrine; 8-Endorphin; Phento-
lamine; Pain (Hu, X.-H. (263) 53)
Lower lip retraction; Dorsal raphe nucleus; 5-HT,, receptor agonist;
8-OH-DPAT ((+)-8-hydroxy-(di-n-propylamino)tetralin); (Rat)
(Berendsen, H.H.G. (263) 315) Ethanol drinking; GABA, receptor; Benzodiazepine; (Selected rat
lines) (Wegelius, K. (263) 141)
Memory Naltriben
Glutamate receptor; Polyamine; lon channel (Shimada, A. (263) 293)
Cocaine; Drug discrimination; Naltrindole; 7-Benzylidenenaltrexone
(Suzuki, T. (263) 207)
[3H] Mesulergine
5-HT;- receptor; Clomipramine; Imipramine; Clorgyline; (Wistar Naltrindole
rat) (Hulihan-Giblin, B.A. (263) 213) Cocaine; Drug discrimination; Naltriben; 7-Benzylidenenaltrexone
(Suzuki, T. (263) 207)
Microdialysis
Haloperidol; Clozapine; Striatum; Glutamate; GABA (y-aminobu- NE-100
tyric acid) (See, R.E. (263) 269) o Receptor; Phencyclidine; Cognition; Neuroleptic; (Rat) (Ogawa,
S.-i. (263) 9)
Microdialysis, intracerebral
5-HT (5-hydroxytryptamine, serotonin) release; Monoamine oxidase Neocortex, human
inhibitor; Antidepressant (Ferrer, A. (263) 227) GABA (y-aminobutyric acid) release; GABA, autoreceptor; CGP
35348; CGP 52432; Phaclofen (Fassio, A. (263) 311)
Mitochondrion
Nerve terminal current
L-DOPA (3,4-dihydroxyphenylalanine); Fibroblast; Parkinson’s dis-
Cholinomimetic; Acetylcholine; Anticholinesterase (Shakiryanova,
ease; Pyruvate oxidation (Werner, P. (263) 157)
D.M. (263) 107)
Mitogenesis
Dopamine D, receptor; Locomotor activity; Dopamine release
NE-100; o Receptor; Phencyclidine; Cognition; (Rat) (Ogawa, S.-i.
(Svensson, K. (263) 235)
(263) 9)
MK-801 Neutrophil, human
Depression, animal model; Anhedonia; CGP 37849; CGP 40116; Priming; Adenosine receptor (Dianzani, C. (263) 223)
Imipramine; (Rat) (Papp, M. (263) 1)
Nicotine
B-Endorphin; Morphine; Tail-flick inhibition; Hot plate inhibition Saphenous artery; Vasodilator nerve; Nitric oxide (NO); CGRP
(Suh, H.-W. (263) 217) (calcitonin gene-related peptide) (Okamura, T. (263) 85)
332 Key word index / European Journal of Pharmacology 263 (1994) 327-333
Nitric oxide (NO) Parkinson’s disease
Saphenous artery; Vasodilator nerve; CGRP (calcitonin gene-related L-DOPA (3,4-dihydroxypheny ine); Mitochondrion; Fibroblast;
peptide); Nicotine (Okamura, T. (263) 85) Pyruvate oxidation (Werner, P. (263) 157)
Gastric mucosa; Mucus; Stomach (Price, K.J. (263) 199) Pentazocine
ACTH (adrenocorticotropic hormone); Corticosterone; Dioxadrol;
Nitric oxide (NO) synthesis Endocrine; NMDA (N-methyl-p-aspartate); Phencyclidine; a Re-
N°®-Nitro-t-arginine methyl ester; LY83583; L158809; Glyben- ceptor; SKF 10,047 (Pechnick, R.N. (263) 115)
clamide; Guanylate cyclase, soluble; K* channel, ATP-sensitive;
Angiotensin AT, receptor antagonist; Hypoxia; Pulmonary circula- Phaclofen
tion; Hypoxic pulmonary vasoconstriction; Pulmonary vascular bed, Neocortex, human; GABA (y-aminobutyric acid) release; GABA,
rat (Feng, C.J. (263) 133) autoreceptor; CGP 35348; CGP 52432 (Fassio, A. (263) 311)
N*®-Nitro-.-arginine methyl ester
Nitric oxide (NO) synthesis; LY83583; L158809; Glybenclamide; NE-100; o Receptor; Cognition; Neuroleptic; (Rat) (O,awa, S.-i.
Guanylate cyclase, soluble; K* channel, ATP-sensitive; Angiotensin (263) 9)
AT, receptor antagonist; Hypoxia; Pulmonary circulation; Hypoxic
pulmonary vasoconstriction; Pulmonary vascular bed, rat (Feng, C.J. ACTH (adrenocorticotropic hormone); Corticosterone; Dioxadrol;
Endocrine; NMDA (N-methyl-p-aspartate); Pentazocine; a Recep-
(263) 133)
tor; SKF 10,047 (Pechnick, R.N. (263) 115)
NMDA (N-methyl-p-aspartate)
Phentolamine
ACTH (adrenocorticotropic hormone); Corticosterone; Dioxadrol;
Indomethacin; Analgesia; Norepinephrine; B-Endorphin; Naloxone;
Endocrine; Pentazocine; Phencyclidine; ao Receptor; SKF 10,047
Pain (Hu, X.-H. (263) 53)
(Pechnick, R.N. (263) 115)
Phorbol ester
Noradrenaline
Muscarinic M, receptor; Muscarinic M, receptor; Mechanistic path-
Acetylcholine; d-Amphetamine; Cortex; Dopamine; 6-Hydroxy-
way; LiCl; Forskolin; 1,9-Dideoxy-forskolin; Vas deferens; (Rabbit)
dopamine (Day, J.C. (263) 285)
(Eltze, M. (263) 31)
N orepinephrine
Phosphodiesterase type V inhibitor
Indomethacin; Analgesia; B-Endorphin; Phentolamine; Naloxone;
E4021; cGMP; Coronary vasodilator; Vasopressin; ST segment eleva-
Pain (Hu, X.-H. (263) 53)
tion (Kodama, K. (263) 93)
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin)
Picrotoxin
5-HT,, receptor; Pain transmission; Antinociception; (Rat) (Cervo,
EBOB (4’-ethynyl-4-n-propylbicycloorthobenzoate); GABA, recep-
L. (263) 187)
tor complex; Brain, human; Autoradiography (Kume, A. (263) 163)
8-OH-DPAT (( + )-8-hydroxy-(di-n-propylamino)tetralin)
Plasma protein extravasation
Lower lip retraction; Dorsal raphe nucleus; Median raphe nucleus;
Dura mater; Tachykinin NK, receptor, a-CGRP-(8-37); GR82334
5-HT,, receptor agonist; (Rat) (Berendsen, H.H.G. (263) 315)
(O’Shaughnessy, C.T. (263) 193)
Omeprazole Polyamine
Gastric ulcer; Cimetidine; Gastrin; Gastric acid (Ito, M. (263) 245) Glutamate receptor; Memory; lon channel (Shimada, A. (263) 293)
Cimetidine; Acid secretion; Gastrin (Ito, M. (263) 253) iso-PPADS (pyridoxalphosphate-6-azophenyI-2’,5’-disulphonic acid)
Px purinoceptor; Suramin; Cibacron blue (Khakh, B.S. (263) 301)
«-Opioid receptor
Primary neuronal culture; Ventral mesencephalon; [*>H]Dopamine P,x purinoceptor
release; Sensitization; Corticosteroid (Ronken, E. (263) 149) iso-PPADS (pyridoxalphosphate-6-azophenyl-2’,5’-disulphonic acid);
Suramin; Cibacron blue (Khakh, B.S. (263) 301)
#2-Opioid receptor
Morphine; Straub tail (Nath, C. (263) 203) Primary neuronal culture
Ventral mesencephalon; x-Opioid receptor; [*H)Dopamine release;
Osteoclast-like cell formation Sensitization; Corticosteroid (Ronken, E. (263) 149)
Vitamin K,; Bone marrow culture; 1,25-Dihydroxyvitamin D,
(Akiyama, Y. (263) 181) Priming
Adenosine receptor; Neutrophil, human (Dianzani, C. (263) 223)
Pain
Indomethacin; Analgesia; Norepinephrine; B-Endorphin; Phento- Prostacyclin
lamine; Naloxone (Hu, X.-H. (263) 53) Adenosine receptor; Adenosine receptor antagonist; Heart, guinea-
pig, perfused (Felsch, A. (263) 261)
Pain transmission
5-HT,, receptor; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetra- Pulmonary circulation
lin); Antinociception; (Rat) (Cervo, L. (263) 187) Nitric oxide (NO) synthesis; N“-Nitro-.-arginine methyl ester;
LY83583; L158809; Glybenclamide; Guanylate cyclase, soluble; K*
Panic disorder channel, ATP-sensitive; Angiotensin AT, receptor antagonist; Hy-
CCK (cholecystokinin); Substance P; Clonazepam; Monoamine up- poxia; Hypoxic pulmonary vasoconsiriction; Pulmonary vascular bed,
take inhititor; Central nervous system, rat (Brodin, K. (263) 175) rat (Feng, C.J. (263) 133)